Literature DB >> 17602783

Nanostructured lipid carriers (NLC) in cosmetic dermal products.

R H Müller1, R D Petersen, A Hommoss, J Pardeike.   

Abstract

The first generation of lipid nanoparticles was introduced as solid lipid nanoparticles (SLN), the second, improved generation as nanostructured lipid carriers (NLC). Identical to the liposomes, the lipid nanoparticles (NLC) appeared as products first on the cosmetic market. The article gives an overview of the cosmetic benefits of lipid nanoparticles, that means enhancement of chemical stability of actives, film formation, controlled occlusion, skin hydration, enhanced skin bioavailability and physical stability of the lipid nanoparticles as topical formulations. NLC are on the market as concentrates to be used as cosmetic excipients, special formulation challenges for these products are discussed. NLC appeared also in a number of finished cosmetic products world-wide. An overview of these products is provided including their special effects due to the lipid nanoparticles, lipids used for their production and incorporated cosmetic actives.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602783     DOI: 10.1016/j.addr.2007.04.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  61 in total

1.  Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.

Authors:  Di Bei; Tao Zhang; James B Murowchick; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2010-08-06       Impact factor: 3.246

2.  Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer.

Authors:  Tanya Vohra; Inderpreet Kaur; Hemraj Heer; Rayasa Ramachandra Murthy
Journal:  Cancer Nanotechnol       Date:  2013-03-16

3.  Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.

Authors:  Cedar H A Boakye; Ketan Patel; Apurva R Patel; Henrique A M Faria; Valtencir Zucolotto; Stephen Safe; Mandip Singh
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 4.  Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.

Authors:  Mayuri Narvekar; Hui Yi Xue; June Young Eoh; Ho Lun Wong
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

5.  Enhancement of antibody production by the addition of Coenzyme-Q(10).

Authors:  Yoshinobu Konno; Motoi Aoki; Masakazu Takagishi; Naoto Sakai; Masamichi Koike; Kaori Wakamatsu; Shinji Hosoi
Journal:  Cytotechnology       Date:  2011-01-01       Impact factor: 2.058

6.  Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.

Authors:  Prasant Nahak; Rahul L Gajbhiye; Gourab Karmakar; Pritam Guha; Biplab Roy; Shila Elizabeth Besra; Alexey G Bikov; Alexander V Akentiev; Boris A Noskov; Kaushik Nag; Parasuraman Jaisankar; Amiya Kumar Panda
Journal:  Pharm Res       Date:  2018-08-27       Impact factor: 4.200

7.  Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone.

Authors:  Bei Li; Zhi-Qiang Ge
Journal:  AAPS PharmSciTech       Date:  2012-01-11       Impact factor: 3.246

8.  Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.

Authors:  Yin-Ku Lin; Zih-Rou Huang; Rou-Zi Zhuo; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2010-03-09

9.  Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis.

Authors:  Kenia Pissinate; Érica dos Santos Martins-Duarte; Scheila Rezende Schaffazick; Catiúscia Padilha de Oliveira; Rossiane Cláudia Vommaro; Sílvia Stanisçuaski Guterres; Adriana Raffin Pohlmann; Wanderley de Souza
Journal:  Parasitol Res       Date:  2013-11-29       Impact factor: 2.289

Review 10.  Nanotechnology applications for the therapy of liver fibrosis.

Authors:  Lydia Giannitrapani; Maurizio Soresi; Maria Luisa Bondì; Giuseppe Montalto; Melchiorre Cervello
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.